Intervention
Physical activity intervention
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 12 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
12 shownRemission of Type 2 Diabetes With Lifestyle InterventionNCT07017127 · 2025-05-01
RECRUITINGA Participatory Approach to Support Glucose Tolerance Tracking in Real-Life of Patients With Type 2 DiabetesNCT06864546 · 2025-05-01
RECRUITINGNo Time to Pause: Physical Activity to Improve Health of Midlife Hispanic WomenNCT06376812 · 2027-01-20
NOT_YET_RECRUITINGPhysical Activity for Adults in the Ontario Breast Screening ProgramNCT06405568 · 2026-08-01
NOT_YET_RECRUITINGA Multidomain Intervention Program for Older People With DementiaNCT04948450 · 2022-11-24
COMPLETEDPhysical Activity Intervention and Cardiovascular Risk Markers in COPDNCT03869112 · 2019-04-01
UNKNOWNPhysical Activity Program and Energy Intake Control in Obese AdolescentsNCT02482220 · 2015-06-01
UNKNOWNPhysical Activity Intervention on Myocardial Function in Patients With HER2 + Breast CancerNCT02433067 · 2015-04-01
TERMINATEDSIT LESS 2: Effect of Sitting Less on Glucose Regulation in People With Diabetes Mellitus Type 2NCT02371239 · 2015-02-01
COMPLETEDLEVEL UP: Video Games for Activity in Breast Cancer SurvivorsNCT02255240 · 2014-09-01
WITHDRAWNPromoting Physical Activity in Patients With Type 2 Diabetes (DIAfit)NCT01289587 · 2011-02-01
COMPLETEDEffects of Zometa and Physical Activity on Bone Density in Women Receiving Chemotherapy for Breast CancerNCT00202059 · 2003-06-01
COMPLETEDCommon conditions
Breast Cancer3Alzheimer Disease1Breast Cancer Female1Cardiovascular Diseases1Cardiovascular Risk Factor1COPD1Dementia1Dementia, Mixed1Diabetes1Diabetes Mellitus Type 21Elevated Blood Pressure1Obese Diabetics1Obesity1Pediatric Obesity1Perimenopause1Physical Inactivity1Type 2 Diabetes1Type 2 Diabetes Mellitus, Non Insulin Dependent1
Leading sponsors
The University of Texas Medical Branch, Galveston
2
Enea Parimbelli
1
HealthPartners Institute
1
Maastricht University Medical Center
1
National Geriatric Hospital
1
Université Blaise Pascal, Clermont-Ferrand
1
University Hospitals, Leicester
1
University of Franche-Comté
1
University of Lausanne Hospitals
1
University of Ottawa
1
University of Split, School of Medicine
1
Trial status mix
COMPLETED4
NOT_YET_RECRUITING2
RECRUITING2
UNKNOWN2
TERMINATED1
WITHDRAWN1
Phase mix
NA11
PHASE31
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.